Our portfolio

Expanded LMIC access to long-acting, reversible contraceptive implant

Bayer, along with private and public organizations, partnered with the foundation to make Jadelle®—an effective, long-acting, reversible contraceptive implant—available to more than 27 million women in the world’s poorest countries at a more than 50 percent price reduction.
Website
  • Domain
    Healthcare Delivery
  • Investment type
    Volume guarantee
  • Status
    Exit
  • Initial investment
    Public
  • Partnered in
    2013
  • Investment lead
    Natalie Revelle
  • Headquarters
    Germany
  • Program strategy
    Family Planning

More about our work

Our focus

Our six domains of focus comprise 40+ program strategies across the Foundation’s nearly $9B annual charitable support.

Investment approach

Fostering partnerships with the private sector to leverage groundbreaking global innovations for societal good.

Our team

We bring depth of experience to every investment, with a proven track record across sectors and scale.